From Name

From Email

To Name

To Email

Message

Gadolinium-based contrast agent does not change diagnostic accuracy of breast diffusion-tensor imaging

from Diagnostic Imaging

Gadolinium-based contrast agent does not change diagnostic accuracy of breast diffusion-tensor imaging Diagnostic Imaging Using a gadolinium-based contrast agent (GBCA) with diffusion-tensor imaging (DTI) does not change the accuracy of breast cancer diagnosis, according to a new study. In an article published in the American Journal of Roentgenology, investigators from Princess Margaret Cancer Center in Toronto, Canada, discussed the impact of GBCA with 3T breast MRI. READ MORE

more